PXS — Provexis Income Statement
0.000.00%
Last trade - 00:00- £14.08m
- £13.06m
- £0.80m
Annual income statement for Provexis, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.348 | 0.505 | 0.426 | 0.39 | 0.802 |
| Cost of Revenue | |||||
| Gross Profit | 0.312 | 0.456 | 0.38 | 0.294 | 0.284 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.773 | 0.865 | 0.666 | 0.811 | 1.41 |
| Operating Profit | -0.425 | -0.359 | -0.24 | -0.421 | -0.604 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.424 | -0.359 | -0.24 | -0.42 | -0.602 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.424 | -0.359 | -0.24 | -0.387 | -0.588 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.406 | -0.341 | -0.224 | -0.385 | -0.586 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.406 | -0.341 | -0.224 | -0.385 | -0.586 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | -0 | -0 | -0 | -0 |